Authors:
EKMAN A
NISSBRANDT H
HEILIG M
DIJKSTRA D
ERIKSSON E
Citation: A. Ekman et al., CENTRAL ADMINISTRATION OF DOPAMINE D3 RECEPTOR ANTISENSE TO RAT - EFFECTS ON LOCOMOTION, DOPAMINE RELEASE AND [H-3]SPIPERONE BINDING, Naunyn-Schmiedeberg's archives of pharmacology, 358(3), 1998, pp. 342-350
Authors:
RODENHUIS N
DIJKSTRA D
DEBOER P
VERMEULEN E
WIKSTROM H
NEUMEYER J
Citation: N. Rodenhuis et al., APOMORPHINE AND SELECTED ANALOGS AS POTENTIAL ANTIPARKINSONIAN AGENTS- A MICRODIALYSIS STUDY, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 714-714
Authors:
BEEKMAN M
UNGARD JT
GASIOR M
CARTER RB
DIJKSTRA D
GOLDBERG SR
WITKIN JM
Citation: M. Beekman et al., REVERSAL OF BEHAVIORAL-EFFECTS OF PENTYLENETETRAZOL BY THE NEUROACTIVE STEROID GANAXOLONE, The Journal of pharmacology and experimental therapeutics, 284(3), 1998, pp. 868-877
Citation: D. Dijkstra et al., A CELEBRATION OF THE 65TH ANNIVERSARY OF ZANDBERGEN,PIETER,J - TEACHER AND RESEARCH LEADER IN APPLIED-MATHEMATICS - DEDICATION, Journal of engineering mathematics, 34(1-2), 1998, pp. 1-2
Authors:
WITKIN J
GASIOR M
ACRI J
BEEKMAN M
THURKAUF A
YUAN J
DEBOER P
WIKSTROM H
DIJKSTRA D
Citation: J. Witkin et al., ATYPICAL ANTIPSYCHOTIC-LIKE EFFECTS OF THE DOPAMINE D-3 RECEPTOR AGONIST, (-PD-128,907()), European journal of pharmacology, 347(2-3), 1998, pp. 1-3
Authors:
HAAS M
MOOLENAAR F
KLUPPEL ACA
DIJKSTRA D
MEIJER DKF
DEZEEUW D
Citation: M. Haas et al., DETERMINATION OF DOPAMINERGIC PRODRUGS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY FOLLOWED BY POSTCOLUMN ION-PAIR EXTRACTION, Journal of chromatography B. Biomedical sciences and applications, 693(2), 1997, pp. 484-488
Authors:
DEBOER P
ENRICO P
WRIGHT J
WISE LD
TIMMERMAN W
MOOR E
DIJKSTRA D
WIKSTROM HV
WESTERINK BHC
Citation: P. Deboer et al., CHARACTERIZATION OF THE EFFECT OF DOPAMINE D-3 RECEPTOR STIMULATION ON LOCOMOTION AND STRIATAL DOPAMINE LEVELS, Brain research, 758(1-2), 1997, pp. 83-91
Authors:
HALL H
HALLDIN C
DIJKSTRA D
WIKSTROM H
WISE LD
PUGSLEY TA
SOKOLOFF P
PAULI S
FARDE L
SEDVALL G
Citation: H. Hall et al., AUTORADIOGRAPHIC LOCALIZATION OF D-3-DOPAMINE RECEPTORS IN THE HUMAN BRAIN USING THE SELECTIVE D-3-DOPAMINE RECEPTOR AGONIST (-[H-3]PD-128907()), Psychopharmacology, 128(3), 1996, pp. 240-247
Authors:
WIKSTROM H
DEBOER P
LIAO Y
DIJKSTRA D
VANVLIET S
PUGSLEY TA
HEFFNER T
MEIER E
Citation: H. Wikstrom et al., NEUROCHEMICAL AND BEHAVIORAL-APPROACHES TO THE CHARACTERIZATION OF TYPICAL AND ATYPICAL NEUROLEPTICS, Journal of neurochemistry, 66, 1996, pp. 13-13
Authors:
VANVLIET LA
TEPPER PG
DIJKSTRA D
DAMSMA G
WIKSTROM H
PUGSLEY TA
AKUNNE HC
HEFFNER TG
GLASE SA
WISE LD
Citation: La. Vanvliet et al., AFFINITY FOR DOPAMINE D-2, D-3, AND D-4 RECEPTORS OF 8-AMINOTETRALINS- RELEVANCE OF D-2 AGONIST BINDING FOR DETERMINATION OF RECEPTOR SUBTYPE SELECTIVITY, Journal of medicinal chemistry, 39(21), 1996, pp. 4233-4237
Authors:
LAHTI RA
MUTIN A
COCHRANE EV
TEPPER PG
DIJKSTRA D
WIKSTROM H
TAMMINGA CA
Citation: Ra. Lahti et al., AFFINITIES AND INTRINSIC ACTIVITIES OF DOPAMINE-RECEPTOR AGONISTS FORTHE HD(21) AND HD(4.4) RECEPTORS, European journal of pharmacology, 301(1-3), 1996, pp. 11-13
Authors:
AKUNNE HC
TOWERS P
ELLIS GJ
DIJKSTRA D
WIKSTROM H
HEFFNER TG
WISE LD
PUGSLEY TA
Citation: Hc. Akunne et al., CHARACTERIZATION OF BINDING OF [H-3]PD-128907, A SELECTIVE DOPAMINE D-3 RECEPTOR AGONIST LIGAND, TO CHO-K1 CELLS, Life sciences, 57(15), 1995, pp. 1401-1410
Authors:
PUGSLEY TA
DAVIS MD
AKUNNE HC
MACKENZIE RG
SHIH YH
DAMSMA G
WIKSTROM H
WHETZEL SZ
GEORGIC LM
COOKE LW
DEMATTOS SB
CORBIN AE
GLASE SA
WISE LD
DIJKSTRA D
HEFFNER TG
Citation: Ta. Pugsley et al., NEUROCHEMICAL AND FUNCTIONAL-CHARACTERIZATION OF THE PREFERENTIALLY SELECTIVE DOPAMINE D3 AGONIST PD-128907, The Journal of pharmacology and experimental therapeutics, 275(3), 1995, pp. 1355-1366
Authors:
SONESSON C
BARF T
NILSSON J
DIJKSTRA D
CARLSSON A
SVENSSON K
SMITH MW
MARTIN IJ
DUNCAN JN
KING LJ
WIKSTROM H
Citation: C. Sonesson et al., SYNTHESIS AND EVALUATION OF PHARMACOLOGICAL AND PHARMACOKINETIC PROPERTIES OF MONOPROPYL ANALOGS OF -[[(TRIFLUOROMETHYL)SULFONYL]OXY]-2-AMINOTETRALIN, -[[(TRIFLUOROMETHYL)SULFONYL]OXY]-2-AMINOTETRALIN, AND 8-[[(TRIFLUOROMETHYL)SULFONYL]OXY]-2-AMINOTETRALIN - CENTRAL DOPAMINE ANDSEROTONIN RECEPTOR ACTIVITY, Journal of medicinal chemistry, 38(8), 1995, pp. 1319-1329
Authors:
ACRI JB
CARTER SR
ALLING K
GETERDOUGLASS B
DIJKSTRA D
WIKSTROM H
KATZ JL
WITKIN JM
Citation: Jb. Acri et al., ASSESSMENT OF COCAINE-LIKE DISCRIMINATIVE STIMULUS EFFECTS OF DOPAMINE D-3 RECEPTOR LIGANDS, European journal of pharmacology, 281(2), 1995, pp. 7-9
Authors:
DAMSMA G
BOTTEMA T
WESTERINK BHC
TEPPER PG
DIJKSTRA D
PUGSLEY TA
MACKENZIE RG
HEFFNER TG
WIKSTROM H
Citation: G. Damsma et al., PHARMACOLOGICAL ASPECTS OF R-(-7-OH-DPAT, A PUTATIVE DOPAMINE D-3 RECEPTOR-LIGAND()), European journal of pharmacology, 249(3), 1993, pp. 180000009-180000010